Ballentine Partners LLC lessened its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 26.5% during the ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on ELV stock, giving a Buy rating on January 16.Invest with ...

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t ...

Health-care companies rose sharply amid strong earnings.

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Elevance Health's quarterly dividend has been increased by 5% to $1.71 per share. The company's president and CEO, Gail K. Boudreaux, expressed the commitment to simplifying the healthcare experience ...

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to ...

Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Elevance Health, Inc. (NYSE:ELV) received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$520 at one point, and dropping to the lows of ...